Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 24758163)


Visual gene-network analysis reveals the cancer gene co-expression in human endometrial cancer.

Chou WC, Cheng AL, Brotto M, Chuang CY.

BMC Genomics. 2014 Apr 23;15:300. doi: 10.1186/1471-2164-15-300.


Weighted gene co-expression network analysis in identification of endometrial cancer prognosis markers.

Zhu XL, Ai ZH, Wang J, Xu YL, Teng YC.

Asian Pac J Cancer Prev. 2012;13(9):4607-11.


Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.

Wong YF, Cheung TH, Lo KW, Yim SF, Siu NS, Chan SC, Ho TW, Wong KW, Yu MY, Wang VW, Li C, Gardner GJ, Bonome T, Johnson WB, Smith DI, Chung TK, Birrer MJ.

Oncogene. 2007 Mar 22;26(13):1971-82. Epub 2006 Oct 16.


Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.

Udyavar AR, Hoeksema MD, Clark JE, Zou Y, Tang Z, Li Z, Li M, Chen H, Statnikov A, Shyr Y, Liebler DC, Field J, Eisenberg R, Estrada L, Massion PP, Quaranta V.

BMC Syst Biol. 2013;7 Suppl 5:S1. doi: 10.1186/1752-0509-7-S5-S1. Epub 2013 Dec 9.


Integrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancer.

Han Y, Huang H, Xiao Z, Zhang W, Cao Y, Qu L, Shou C.

PLoS One. 2012;7(12):e52745. doi: 10.1371/journal.pone.0052745. Epub 2012 Dec 27.


Robust gene network analysis reveals alteration of the STAT5a network as a hallmark of prostate cancer.

Reddy A, Huang CC, Liu H, Delisi C, Nevalainen MT, Szalma S, Bhanot G.

Genome Inform. 2010;24:139-53.


Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer.

Risinger JI, Maxwell GL, Chandramouli GV, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC.

Cancer Res. 2003 Jan 1;63(1):6-11.


ERβ-dependent effects on uterine endothelial cells are cell specific and mediated via Sp1.

Greaves E, Collins F, Critchley HO, Saunders PT.

Hum Reprod. 2013 Sep;28(9):2490-501. doi: 10.1093/humrep/det235. Epub 2013 Jun 11.


Identifying cancer biomarkers by network-constrained support vector machines.

Chen L, Xuan J, Riggins RB, Clarke R, Wang Y.

BMC Syst Biol. 2011 Oct 12;5:161. doi: 10.1186/1752-0509-5-161.


The Krüppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression.

Simmen FA, Su Y, Xiao R, Zeng Z, Simmen RC.

Reprod Biol Endocrinol. 2008 Sep 10;6:41. doi: 10.1186/1477-7827-6-41.


Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.

Colak D, Nofal A, Albakheet A, Nirmal M, Jeprel H, Eldali A, Al-Tweigeri T, Tulbah A, Ajarim D, Malik OA, Inan MS, Kaya N, Park BH, Bin Amer SM.

PLoS One. 2013 May 21;8(5):e63204. doi: 10.1371/journal.pone.0063204. Print 2013.


Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.

Zhang X, Dong Y, Ti H, Zhao J, Wang Y, Li T, Zhang B.

Hum Pathol. 2013 Nov;44(11):2571-80. doi: 10.1016/j.humpath.2013.07.002. Epub 2013 Sep 24.


Role of circulating free alu DNA in endometrial cancer.

Tanaka H, Tsuda H, Nishimura S, Nomura H, Kataoka F, Chiyoda T, Tanaka K, Iguchi Y, Susumu N, Aoki D.

Int J Gynecol Cancer. 2012 Jan;22(1):82-6. doi: 10.1097/IGC.0b013e3182328c94.


Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women.

Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, Le Shay N, Nezhat CN, Kempson R, Lessey BA, Nayak NR, Giudice LC.

Endocrinology. 2006 Mar;147(3):1097-121. Epub 2005 Nov 23.


Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.

Jones A, Teschendorff AE, Li Q, Hayward JD, Kannan A, Mould T, West J, Zikan M, Cibula D, Fiegl H, Lee SH, Wik E, Hadwin R, Arora R, Lemech C, Turunen H, Pakarinen P, Jacobs IJ, Salvesen HB, Bagchi MK, Bagchi IC, Widschwendter M.

PLoS Med. 2013 Nov;10(11):e1001551. doi: 10.1371/journal.pmed.1001551. Epub 2013 Nov 12.


Microsatellite instability in endometrial cancer: relation to histological subtypes.

Tibiletti MG, Furlan D, Taborelli M, Facco C, Riva C, Franchi M, Cossu A, Trubia M, Taramelli R, Capella C.

Gynecol Oncol. 1999 May;73(2):247-52.


[Study of differential gene expression in different stage human endometrial cancer].

Wan XP, Cai B, Liu L, Xi XW, Yang YX.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):38-42. Chinese.


When is hub gene selection better than standard meta-analysis?

Langfelder P, Mischel PS, Horvath S.

PLoS One. 2013 Apr 17;8(4):e61505. doi: 10.1371/journal.pone.0061505. Print 2013.


MicroRNA signatures differentiate uterine cancer tumor subtypes.

Ratner ES, Tuck D, Richter C, Nallur S, Patel RM, Schultz V, Hui P, Schwartz PE, Rutherford TJ, Weidhaas JB.

Gynecol Oncol. 2010 Sep;118(3):251-7. doi: 10.1016/j.ygyno.2010.05.010. Epub 2010 Jun 9.


Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.

Cassia R, Moreno-Bueno G, Rodríguez-Perales S, Hardisson D, Cigudosa JC, Palacios J.

J Pathol. 2003 Dec;201(4):589-95.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk